O43772 (MCAT_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
November 16, 2011.
Version 108.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Mitochondrial carnitine/acylcarnitine carrier protein Alternative name(s): Carnitine/acylcarnitine translocase Short name=CAC Solute carrier family 25 member 20 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 301 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates the transport of acylcarnitines of different length across the mitochondrial inner membrane from the cytosol to the mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. |
| Subcellular location | |
| Involvement in disease | Defects in SLC25A20 are the cause of carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138]. It is an autosomal recessive deficiency in mitochondrial oxidation of fatty acids. It is usually lethal within a few hours or days after birth. Symptoms characterizing its normally severe clinical phenotype include fatty hepatomegaly with abnormal liver function, cardiomyopathy, muscle weakness and episodes of life-threatening coma, which eventually lead to death. Ref.1 |
| Sequence similarities | Belongs to the mitochondrial carrier family. Contains 3 Solcar repeats. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Membrane Mitochondrion Mitochondrion inner membrane |
| Disease | Disease mutation |
| Domain | Repeat Transmembrane Transmembrane helix |
| PTM | Acetylation |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | carnitine shuttle Traceable author statement. Source: Reactome cellular lipid metabolic processTraceable author statement. Source: Reactome regulation of fatty acid oxidationTraceable author statement. Source: Reactome |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW mitochondrial inner membraneTraceable author statement. Source: Reactome |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 301 | 301 | Mitochondrial carnitine/acylcarnitine carrier protein | PRO_0000090628 | |||||
Regions | |||||||||
| Topological domain | 1 – 12 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 13 – 31 | 19 | Helical; Name=1; Potential | ||||||
| Topological domain | 32 – 73 | 42 | Mitochondrial matrix Potential | ||||||
| Transmembrane | 74 – 93 | 20 | Helical; Name=2; Potential | ||||||
| Topological domain | 94 – 112 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 113 – 131 | 19 | Helical; Name=3; Potential | ||||||
| Topological domain | 132 – 170 | 39 | Mitochondrial matrix Potential | ||||||
| Transmembrane | 171 – 190 | 20 | Helical; Name=4; Potential | ||||||
| Topological domain | 191 – 211 | 21 | Cytoplasmic Potential | ||||||
| Transmembrane | 212 – 230 | 19 | Helical; Name=5; Potential | ||||||
| Topological domain | 231 – 267 | 37 | Mitochondrial matrix Potential | ||||||
| Transmembrane | 268 – 287 | 20 | Helical; Name=6; Potential | ||||||
| Topological domain | 288 – 301 | 14 | Cytoplasmic Potential | ||||||
| Repeat | 8 – 99 | 92 | Solcar 1 | ||||||
| Repeat | 108 – 196 | 89 | Solcar 2 | ||||||
| Repeat | 207 – 293 | 87 | Solcar 3 | ||||||
Amino acid modifications | |||||||||
| Modified residue | 148 | 1 | N6-acetyllysine By similarity | ||||||
| Modified residue | 244 | 1 | N6-acetyllysine By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 133 | 1 | R → W in CACT deficiency. Ref.8 | VAR_021818 | |||||
| Natural variant | 231 | 1 | D → H in CACT deficiency. Ref.8 | VAR_021819 | |||||
| Natural variant | 238 | 1 | Q → R in CACT deficiency. Ref.6 Ref.7 Corresponds to variant rs28934589 [ dbSNP | Ensembl ]. | VAR_021820 | |||||
Experimental info | |||||||||
| Sequence conflict | 203 | 1 | R → S in CAB55356. Ref.2 | ||||||
| Sequence conflict | 240 | 1 | A → G in CAB55356. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient." Huizing M., Iacobazzi V., Ijlst L., Savelkoul P., Ruitenbeek W., van den Heuvel L., Indiveri C., Smeitink J., Trijbels F., Wanders R., Palmieri F. Am. J. Hum. Genet. 61:1239-1245(1997) [PubMed: 9399886] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], DISEASE. Tissue: Liver. |
| [2] | "The structure and organization of the human carnitine/acylcarnitine translocase (CACT) gene." Iacobazzi V., Naglieri M.A., Stanley C.A., Wanders R.J.A., Palmieri F. Biochem. Biophys. Res. Commun. 252:770-774(1998) [PubMed: 9837782] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Skin. |
| [5] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [6] | "A novel molecular defect of the carnitine acylcarnitine translocase gene in a Saudi patient." Al-Aqeel A.I., Rashid M.S., Ruiter J.P., Ijlst L., Wanders R.J.A. Clin. Genet. 64:163-165(2003) [PubMed: 12859414] [Abstract] Cited for: VARIANT CACT DEFICIENCY ARG-238. |
| [7] | "Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation." Iacobazzi V., Pasquali M., Singh R., Matern D., Rinaldo P., Amat di San Filippo C., Palmieri F., Longo N. Am. J. Med. Genet. A 126:150-155(2004) [PubMed: 15057979] [Abstract] Cited for: VARIANT CACT DEFICIENCY ARG-238. |
| [8] | "Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency." Iacobazzi V., Invernizzi F., Baratta S., Pons R., Chung W., Garavaglia B., Dionisi-Vici C., Ribes A., Parini R., Huertas M.D., Roldan S., Lauria G., Palmieri F., Taroni F. Hum. Mutat. 24:312-320(2004) [PubMed: 15365988] [Abstract] Cited for: VARIANTS CACT DEFICIENCY TRP-133 AND HIS-231. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Y10319 mRNA. Translation: CAA71367.1. Y17775 Y17779 Genomic DNA. Translation: CAB55356.1.AK312962 mRNA. Translation: BAG35801.1. BC001689 mRNA. Translation: AAH01689.1. |
| IPI | IPI00013957. |
| RefSeq | NP_000378.1. NM_000387.5. |
| UniGene | Hs.13845. |
3D structure databases | |
| ProteinModelPortal | O43772. |
| SMR | O43772. Positions 6-298. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O43772. 1 interaction. |
| MINT | MINT-1370660. |
| STRING | O43772. |
Protein family/group databases | |
| TCDB | 2.A.29.8.3. mitochondrial carrier (MC) family. |
PTM databases | |
| PhosphoSite | O43772. |
Proteomic databases | |
| PeptideAtlas | O43772. |
| PRIDE | O43772. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000319017; ENSP00000326305; ENSG00000178537. |
| GeneID | 788. |
| KEGG | hsa:788. |
| UCSC | uc003cva.2. human. |
Organism-specific databases | |
| CTD | 788. |
| GeneCards | GC03M048869. |
| H-InvDB | HIX0200528. |
| HGNC | HGNC:1421. SLC25A20. |
| HPA | HPA016862. HPA029863. |
| MIM | 212138. phenotype. 613698. gene. |
| neXtProt | NX_O43772. |
| Orphanet | 159. Carnitine-acylcarnitine translocase deficiency. |
| PharmGKB | PA35031. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG11754. |
| GeneTree | ENSGT00600000084077. |
| HOGENOM | HBG735918. |
| HOVERGEN | HBG003500. |
| InParanoid | O43772. |
| OMA | FTTAIMA. |
| OrthoDB | EOG4WM4V6. |
| PhylomeDB | O43772. |
Enzyme and pathway databases | |
| Reactome | REACT_11163. Activated AMPK stimulates fatty-acid oxidation in muscle. REACT_22258. Metabolism of lipids and lipoproteins. |
Gene expression databases | |
| ArrayExpress | O43772. |
| Bgee | O43772. |
| CleanEx | HS_SLC25A20. |
| Genevestigator | O43772. |
| GermOnline | ENSG00000178537. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018108. Mitochondrial_sb/sol_carrier. IPR023395. Mt_carrier_dom. [Graphical view] |
| Gene3D | G3DSA:1.50.40.10. G3DSA:1.50.40.10. 1 hit. |
| KO | K15109. |
| Pfam | PF00153. Mito_carr. 3 hits. [Graphical view] |
| SUPFAM | SSF103506. Mitoch_carrier. 1 hit. |
| PROSITE | PS50920. SOLCAR. 3 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| DrugBank | DB00583. L-Carnitine. |
| NextBio | 3206. |
| SOURCE | Search... |
Entry information
| Entry name | MCAT_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O43772 Secondary accession number(s): B2R7F4, Q9UIQ2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with